BPC-157+TB-500
Combination of two leading recovery peptides. Popular protocol for injury treatment and accelerated recovery.
Select Size
Select Bundle
Compound
BPC-157+TB-500
Form
Lyophilized Powder
Purity
>99%
Storage
-20°C
Science
Mechanism of Action
BPC-157 is a synthetic pentadecapeptide derived from human gastric juice that promotes angiogenesis, modulates the nitric oxide (NO) system, and upregulates growth hormone receptors and VEGFR2. It demonstrates cytoprotective and wound-healing properties across multiple tissue types including tendons, muscles, and the gastrointestinal tract.
Benefits
Research Benefits
- Accelerated tendon-to-bone healing in animal models
- Reduced recovery time from muscle tears and ligament injuries
- Gastrointestinal protective effects (ulcer healing)
- Promotes angiogenesis and new blood vessel formation
- Anti-inflammatory properties via NO pathway modulation
- Neuroprotective effects observed in preclinical studies
Research
Dosage Protocol
Research protocols typically use 250-500mcg daily via subcutaneous injection, often split into two doses. Oral formulations studied at 250mcg-500mcg for GI applications. Cycle lengths of 2-4 weeks are common in research settings.
Technical Specifications
Research Comparison
Compare Specs Side-by-Side
| Peptide | ||
|---|---|---|
| Aliases | Body Protection Compound 157 | |
| CAS Number | 137525-51-0 | |
| Molecular Weight | 1419.55 g/mol | |
| Sequence | GEPPPGKPADDAGLV | |
| Purity | >99% (HPLC) | |
| Form | Lyophilized Powder | |
| Storage | -20°C | |
| Price | £44 | |
| Mechanism | BPC-157 is a synthetic pentadecapeptide derived from human gastric juice that promotes angiogenesis, modulates the nitric oxide (NO) system, and upregulates growth hormone receptors and VEGFR2. It demonstrates cytoprotective and wound-healing properties across multiple tissue types including tendons, muscles, and the gastrointestinal tract. | |
| Dosage Protocol | Research protocols typically use 250-500mcg daily via subcutaneous injection, often split into two doses. Oral formulations studied at 250mcg-500mcg for GI applications. Cycle lengths of 2-4 weeks are common in research settings. |
Comparison for research purposes only · All peptides >99% HPLC-verified purity
Stability
Storage Guidelines
Store lyophilized powder at -20°C. Reconstituted solution stable at 2-8°C for up to 30 days. Protect from light. Avoid freeze-thaw cycles.
Safety
Safety & Effects
BPC-157 has shown an excellent safety profile in animal studies with no reported toxicity at therapeutic doses. No significant adverse effects have been documented in published research literature.
Scientific Literature
Published Research
Journal of Applied Physiology, 2011
BPC-157 and Tendon Healing
Accelerated tendon-to-bone healing in rat models
PubMed →Current Pharmaceutical Design, 2018
BPC-157 Cytoprotective Effects
Multiple organ protective effects demonstrated
PubMed →World Journal of Gastroenterology, 2010
BPC-157 and Angiogenesis
Promotes VEGFR2 upregulation and blood vessel formation
PubMed →Research Tool
Peptide Reconstitution Calculator
Calculate precise dosing with a visual syringe ruler
Visual Reconstitution Calculator
Select your parameters and get precise instructions with a visual syringe ruler
What is the total volume of your syringe?
What is your peptide vial quantity?
How much bacteriostatic water are you adding?
What is the dose?
For a dose of 20 units pull the syringe to 20
Units to Draw
20 U
Volume
0.200 ml
Concentration
50 mcg/U
Total Doses
10
Research use only · Not for human consumption
Shopping Cart
(0)Your cart is empty